Today's patients have unique cardiologic needs before, during, and after cancer treatment. Chemotherapies, radiation therapy, and targeted therapies can produce acute side effects or lasting adverse consequences on the heart and circulatory system, making the field of cardio-oncology increasingly important in effective patient care. Cardio-Oncology Practice Manual is a comprehensive, portable guide that provides practical approaches to assessment and management of cardiovascular diseases due to the effects of cardiotoxic agents and treatments. Part of the Braunwald family of renowned cardiology references, it clearly presents clinically relevant aspects of this growing field in one quick, practical reference for a wide range of cardio-oncology providers.
Key Features
- Covers all major cancer therapies, cardiovascular toxicities, and malignancies in a portable, authoritative guide -ideal for cardiologists, cardio-oncologists, general practitioners, internists, medical oncologists, and hematologists.
- Offers templated and streamlined content for quick retrieval, with key point summaries for each major section.
- Presents cardiac disease entities and specific malignant diseases in a succinct overview format addressing important clinical care aspects.
- Features "Central Illustrations" for each topic that visually summarize the chapter and its specific content including algorithms for management of cardiovascular toxicities and one-view overviews of malignancies.
- Includes a comprehensive drug guide that provides quick reference to drugs prescribed for cancers with therapeutic indications, manifestations and mechanisms of cardiotoxicity, their risk factors, and risk reduction strategies.
- Brings you up to date with new immune therapies, including immune checkpoint inhibitors and CAR T-cell therapies
- Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.
| ISBN | 9780323681353 |
|---|---|
| Product Format | Book |
| Publication Date | 2022 |
| Author Information | Edited by Joerg Herrmann, MD, Professor of Medicine, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota |
| Published Reviews | "Overall, the book provides a succinct blueprint for the field of cardio-oncology. It informs its readers of the ideology necessary to provide quality clinical care in this specific area of medicine and shapes the direction that the field of cardio-oncology will likely take as its importance continues to increase over the coming years." ©Doody's Review Service, 2022, Joseph T Hale, MD MPH Candidate (East Tennessee State University Quillen College of Medicine) Doody's Score: 4 Stars! |
| Table of Content | 1 The Cardio-Oncology Clinic: Goals, Scope, and Focus of Practice 2 Key Points of Cardio-Oncology Evaluation Before Cancer Therapy 3 Cardiovascular Risks of Chemotherapy 4 Radiation Therapy Cardiovascular Risks 5 Bone Marrow Transplantation Risk 6 Surgical Risks 7 Prevention of Heart Failure and Cardiomyopathy in Patients With Cancer 8 Vascular Disease Prevention: Before Cancer Therapy 9 Thromboembolic Disease Prevention: Before Cancer Therapy 10 Arrhythmia Prevention and Device Management: Before Cancer Therapy 11 Hypertension and Renal Disease Prevention: Before Cancer Therapy 12 Prevention and Management of Pulmonary Conditions in Cancer Patients Before Therapy 13 Cardiopulmonary Exercise for Prevention: Before Cancer Therapy 14 Key Points of Cardio-Oncology Evaluation During Cancer Therapy 15 Diagnosis and Management of Cardiomyopathy and Heart Failure During Cancer Treatment 16 Structural Heart Disease Mangement During Cancer Treatment 17 Vascular Disease During Cancer Therapy 18 Thromboembolic Disease During Cancer Therapy 19 Arrhythmia and Device Assessment During Cancer Treatments 20 Hypertension and Renal Disease During Anti-Cancer Therapies 21 Pulmonary Disease During Cancer Therapy 22 Cardiovascular Testing In The Cancer Patient 23 Key Points of Cardio-Oncology Evaluation After Cancer Therapy 24 Cancer Survivorship and Comorbidity Disease Risk After Cancer Treatment 25 Long-Term Complications of Chemotherapy 26 Long-Term Complications of Radiation Therapy 27 Cardiopulmonary Rehabilitation 27 Prevention and Management of Heart Disease in Cancer Survivors 28 Structural Heart Disease Prevention and Management in Cancer Survivors 29 Vascular Disease Prevention and Management After Cancer Therapy 30 Prevention of VTE After Initial Presentation and Cancer Treatment 31 Arrhythmia Prevention and Management in Cancer Survivors 32 Hypertension and Renal Failure Prevention and Management After Cancer Therapy 33 Monitoring for and Management of Delayed Complications After Cancer Therapy 34 Cardiopulmonary Rehabilitation for Cancer Patients and Survivors 35 Breast Cancer 36 Gynecologic Malignancies 37 Prostate and Testicular Cancer 38 Renal and Urinary Bladder Cancer 39 Lung Cancer 40 Colorectal Cancer 41 Esophageal and Gastric Cancer 42 Hepatobiliary Carcinomas 43 Pancreatic Cancer 44 Cutaneous Melanoma 45 Head-and-Neck Cancers 46 Thyroid cancer 47 Glioblastoma 48 Introduction to the Management of Soft Tissue Sarcomas 49 Acute and Chronic Leukemias 50 Lymphomas 51 Multiple Myeloma and Cardiac Amyloidosis 52 Carcinoid Tumors and Carcinoid Heart Disease 53 Neoplasms and The Heart 54 Cancer Therapeutic Drug Guide |
| Publication Date | 07-03-2022 |
| Pages | 432 |
| Trim | 235 x 191 (7 1/2 x 9 1/4) |
| Stock Status | Coming Soon |
| deltacomm1code | Books |
